RAPT Therapeutics Inc (RAPT)
1.57
-0.14
(-8.19%)
USD |
NASDAQ |
Nov 13, 16:00
1.565
0.00 (0.00%)
After-Hours: 20:00
RAPT Therapeutics Price: 1.57 for Nov. 13, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2024 | 1.735 | 1.892 | 1.52 | 1.57 | 1.168M |
| Nov 12, 2024 | 1.76 | 1.955 | 1.70 | 1.71 | 2.388M |
| Nov 11, 2024 | 1.52 | 1.828 | 1.305 | 1.75 | 7.440M |
| Nov 08, 2024 | 3.10 | 3.14 | 2.67 | 2.89 | 491366.0 |
| Nov 07, 2024 | 2.74 | 3.17 | 2.61 | 3.10 | 595536.0 |
| Nov 06, 2024 | 2.54 | 3.32 | 2.44 | 2.72 | 1.494M |
| Nov 05, 2024 | 2.26 | 2.45 | 2.18 | 2.45 | 248903.0 |
| Nov 04, 2024 | 2.27 | 2.485 | 2.16 | 2.27 | 352091.0 |
| Nov 01, 2024 | 2.15 | 2.385 | 2.14 | 2.23 | 319751.0 |
| Oct 31, 2024 | 2.20 | 2.27 | 2.09 | 2.12 | 310176.0 |
| Oct 30, 2024 | 2.00 | 2.50 | 1.98 | 2.20 | 780936.0 |
| Oct 29, 2024 | 1.91 | 2.22 | 1.91 | 2.00 | 536700.0 |
| Oct 28, 2024 | 1.88 | 2.015 | 1.87 | 1.93 | 128094.0 |
| Oct 25, 2024 | 1.77 | 1.92 | 1.74 | 1.89 | 218700.0 |
| Oct 24, 2024 | 1.74 | 1.815 | 1.70 | 1.77 | 215496.0 |
| Oct 23, 2024 | 1.76 | 1.80 | 1.66 | 1.72 | 172431.0 |
| Oct 22, 2024 | 1.67 | 1.79 | 1.66 | 1.79 | 172693.0 |
| Oct 21, 2024 | 1.79 | 1.82 | 1.64 | 1.645 | 223483.0 |
| Oct 18, 2024 | 1.70 | 1.83 | 1.70 | 1.79 | 268791.0 |
| Oct 17, 2024 | 1.74 | 1.74 | 1.67 | 1.69 | 125998.0 |
| Oct 16, 2024 | 1.83 | 1.83 | 1.731 | 1.75 | 114423.0 |
| Oct 15, 2024 | 1.92 | 1.92 | 1.80 | 1.81 | 118457.0 |
| Oct 14, 2024 | 1.82 | 1.93 | 1.805 | 1.93 | 199818.0 |
| Oct 11, 2024 | 1.68 | 1.82 | 1.68 | 1.82 | 155752.0 |
| Oct 10, 2024 | 1.88 | 1.88 | 1.66 | 1.67 | 259822.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.57
Minimum
Nov 13 2024
48.86
Maximum
Jan 27 2020
20.84
Average
21.08
Median
Price Benchmarks
| Biomarin Pharmaceutical Inc | 66.66 |
| Arbutus Biopharma Corp | 3.65 |
| GlycoMimetics Inc | 0.402 |
| FibroGen Inc | 0.3306 |
| Cidara Therapeutics Inc | 13.94 |
Price Related Metrics
| PS Ratio | 18.57 |
| PEG Ratio | -0.1056 |
| Price to Book Value | 0.5002 |
| Earnings Yield | -200.0% |
| Market Cap | 54.62M |
| PEGY Ratio | -0.1056 |